The MHRA's raid follows an uptick in the trade of illegal GLP-1RA drugs used for obesity and type 2 diabetes amid shortages ...
Dupixent’s Q3 sales increased by 26.2%, breaking through the €4bn ceiling for the first time in a single quarter.
Lilly and Inctye will be seeking a label update for the JAK inhibitor for its use in paediatric patients with alopecia areata ...
Galderma becomes the latest European pharma company to heavily invest in the US this year amid pressures from President ...
EUROAPI has announced Med4Cure, an initiative within the Health Important Project of Common European Interest (IPCEI) ...
GSK has received US Food and Drug Administration (FDA) approval for Blenrep to be used along with BVd for multiple myeloma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback